Managing Editor – Europe
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Tom Gallen
OTC ranitidine products are among the first to be recalled in Europe following the discovery of a human carcinogen in ranitidine-based drugs.With investigations underway worldwide, regulators across Europe are split into two camps: immediate action or wait and see.
A new dedicated R&D facility for Bayer Consumer Health in China will enable the firm to “quickly take the pulse of the market” and transform demand into innovative products.
Omega-3, folate and amino acid supplements are an effective additional treatment for number of mental health conditions including depression and bipolar disorder, show the results of a major study.
The NHS wants to make high-dose statins available OTC in the UK and will work with regulators and industry to make it happen. Such a switch could open up a whole new consumer health category in the country, moving the industry into treatments for chronic conditions.